These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Audio Interview: An International Look at Covid-19. Rubin EJ; Baden LR; Nottage K; O'Connell J; Wong G; Morrissey S N Engl J Med; 2021 Jan; 384(3):e19. PubMed ID: 33471986 [No Abstract] [Full Text] [Related]
5. [The vaccines are here: Are we ready?]. Ruiz F; Fernández-Niño J Biomedica; 2021 Mar; 41(1):5-7. PubMed ID: 33761184 [No Abstract] [Full Text] [Related]
6. Public health experts are learning from Canada's anti-mask protests. Hapuhennedige S CMAJ; 2020 Oct; 192(42):E1274-E1275. PubMed ID: 33077526 [No Abstract] [Full Text] [Related]
7. Can COVID-19 vaccines stop the pandemic? Lau CS Hong Kong Med J; 2021 Apr; 27(2):84-85. PubMed ID: 33879622 [No Abstract] [Full Text] [Related]
8. Lessons from the United Kingdom's COVID-19 vaccination strategy. Harnden A; Earnshaw A Med J Aust; 2021 May; 214(9):417-419. PubMed ID: 33893643 [No Abstract] [Full Text] [Related]
9. Restoring confidence in vaccines in the COVID-19 era. Verger P; Dubé E Expert Rev Vaccines; 2020 Nov; 19(11):991-993. PubMed ID: 32940574 [No Abstract] [Full Text] [Related]
10. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. Makhoul AT; Drolet BC Chest; 2021 Mar; 159(3):1292-1293. PubMed ID: 33453180 [No Abstract] [Full Text] [Related]
11. Public opinion on global rollout of COVID-19 vaccines. Clarke PM; Roope LSJ; Loewen PJ; Bonnefon JF; Melegaro A; Friedman J; Violato M; Barnett A; Duch R Nat Med; 2021 Jun; 27(6):935-936. PubMed ID: 33785911 [No Abstract] [Full Text] [Related]
13. Boosting the nation against covid-19: are the vaccination targets feasible? Osama T; Hodes S; Razai MS; Majeed A BMJ; 2021 Dec; 375():n3094. PubMed ID: 34911679 [No Abstract] [Full Text] [Related]
14. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193 [No Abstract] [Full Text] [Related]
15. Seeking to address issues with COVID-19 vaccines in Japan and to resolve global problems with vaccination programmes. Inoue K; Ohira Y; Kawano N; Takeshita H; Hashioka S Int Marit Health; 2021; 72(2):142. PubMed ID: 34212355 [No Abstract] [Full Text] [Related]
18. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556 [No Abstract] [Full Text] [Related]
19. An exceptional vaccination policy in exceptional circumstances. The Lancet Infectious Diseases Lancet Infect Dis; 2021 Feb; 21(2):149. PubMed ID: 33460564 [No Abstract] [Full Text] [Related]
20. Key steps in our journey to a COVID-19 vaccine program. Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153 [No Abstract] [Full Text] [Related] [Next] [New Search]